Literature DB >> 17661761

An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.

A Floreani1, E Rosa Rizzotto, D Basso, F Navaglia, M Zaninotto, I Petridis, O DI Andrea, R Testa, M Marra, V Baldo, M Chiaramonte.   

Abstract

BACKGROUND: The C282Y mutation in the HFE gene is responsible for most cases of hereditary haemochromatosis. AIM: To investigate the allele frequency of HFE mutations and the associations between mutations and cases of iron overload or liver diseases in an open population of Central Italy.
METHODS: A total of 502 individuals over 8 years of age, comprising 203 males and 299 females, who were residents in Arsita (a small town in Central Italy), were assayed for: C282Y, H63D and S65C mutations of the HFE gene by TaqMan probes; body mass index, serum ferritin, transferrin saturation, transaminases, GGT, glucose, insulin, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, HBV and HCV serum markers. Information was obtained on alcohol intake. Liver ultrasound was performed in 334 (67%) subjects.
RESULTS: The allele frequencies for C282Y, H63D and S65C were 2%, 15%, and 0.01%, respectively. C282Y/wt was found in 19 subjects (4%), H63D/wt in 127 (25%), H63D/H63D in 11 (2%) and S65C/wt in one (2.0 per thousand). No homozygosity for C282Y or compound mutation (C282Y/H63D) was found in the study population, but 27 subjects (5%) had TfSat >45% (including 10 subjects with high serum ferritin). Overall, 49 subjects (9.8%) were HCV-RNA-positive. Logistic regression analysis indicated that male gender (P = 0.000) and hepatic steatosis (P = 0.017) were independent variables correlating to a high serum ferritin.
CONCLUSION: C282Y HFE mutation is less frequent in Central Italy than in Northern Italy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661761     DOI: 10.1111/j.1365-2036.2007.03401.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

Review 1.  Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ruben Hernaez; Edwina Yeung; Jeanne M Clark; Kris V Kowdley; Frederick L Brancati; Wen Hong Linda Kao
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

2.  Frequency of mutations related to hereditary haemochromatosis in northwestern Poland.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Janina Suchy; Iwona Zawada; Jan Lubinski; Piotr Milkiewicz
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

3.  Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls.

Authors:  Pietro Invernizzi; Carlo Selmi; Francesca Poli; Sara Frison; Annarosa Floreani; Domenico Alvaro; Piero Almasio; Floriano Rosina; Marco Marzioni; Luca Fabris; Luigi Muratori; Lihong Qi; Michael F Seldin; M Eric Gershwin; Mauro Podda
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

4.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

5.  Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.

Authors:  Reham M Dawood; Mai Abd El Meguid; Walied Elrobe; Ghada M Salum; Naglaa Zayed; Sherief Mousa; Eman Medhat
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.